Related Experiment Videos
Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease
1Department of Pediatrics, Northwestern University, Children's Memorial Hospital, Chicago, Illinois 60614.
Abstract:
Chronic granulomatous disease (CGD) is characterized by defective killing of intracellular microorganisms due to mutations in one of the four known components of the NADPH oxidase system. This system is responsible for the generation of superoxide and related antimicrobial oxidants. Diagnosis of CGD requires the demonstration of an abnormal oxidase system in the leukocytes of affected patients. Recently, several flow cytometry-based procedures which measure various reactive oxygen intermediates generated by the NADPH oxidase system have been developed. Most of the procedures developed to date require time-consuming granulocyte isolation, washing, and counting procedures, or they lack sensitivity. We have modified an existing procedure such that cell labelling and stimulation are performed directly in whole blood. Optimization of this procedure and its use in the diagnosis of patients with CGD or X-linked carriers are presented.
Insights
Diagnosing Chronic Granulomatous Disease (CGD) is improved with a new, faster flow cytometry method. This optimized whole-blood technique aids in identifying CGD patients and carriers more efficiently.
Area of Science:
- Immunology
- Medical Diagnostics
- Molecular Biology
Background:
- Chronic Granulomatous Disease (CGD) involves impaired intracellular microorganism killing due to NADPH oxidase system defects.
- The NADPH oxidase system generates superoxide and other oxidants crucial for antimicrobial activity.
- Accurate diagnosis of CGD relies on detecting abnormalities in the leukocyte oxidase system.
Purpose of the Study:
- To develop and optimize a sensitive, rapid flow cytometry assay for CGD diagnosis.
- To adapt existing procedures for direct use on whole blood, minimizing sample preparation.
- To evaluate the assay's utility in diagnosing CGD patients and X-linked carriers.
Main Methods:
- Modification of an existing flow cytometry procedure for direct whole-blood analysis.
- Optimization of cell labeling and stimulation steps within the whole-blood context.
- Application of the optimized assay for diagnosing individuals with suspected CGD or carrier status.
Main Results:
- The modified whole-blood procedure streamlines sample handling by eliminating granulocyte isolation and washing steps.
- The assay demonstrates sensitivity suitable for diagnosing CGD and identifying carriers.
- Optimized conditions facilitate accurate assessment of NADPH oxidase function in leukocytes.
Conclusions:
- A simplified, rapid flow cytometry assay using whole blood is effective for diagnosing CGD.
- This optimized method offers a practical alternative to existing, more labor-intensive diagnostic procedures.
- The assay is valuable for identifying both CGD patients and their X-linked carriers.